Concepedia

Author

Alfredo M. Rodriguez–Granillo

Sanatorio Otamendi y MiroliORCID

Also Known As

A Matias Rodriguez-Granillo, A Matías Rodríguez-Granillo, A. Matias Rodriguez‐Granillo, A. Matías Rodriguez-Granillo, A. Matías Rodríguez-Granillo, A. Rodriguez-Granillo, A.M. Rodriguez-Granillo, Alfredo M Rodriguez-Granillo, Alfredo M Rodríguez-Granillo, Alfredo M. RODRIGUEZ-GRANILLO

54

Publications

706

Citations

12

H-Index

14

Concepts

All Affiliations

Sanatorio Otamendi y MiroliMassachusetts General HospitalAzienda Ospedaliero-Universitaria CareggiCentro de Investigaciones Cardiovasculares
AM

About

Alfredo M. Rodriguez–Granillo is an author at Sanatorio Otamendi y Miroli specializing in medicine, surgery, and coronary heart disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

329

2

Percutaneous Coronary Intervention

3

3

137

3

Diabetes

1

1

28

4

Emergency Medicine

1

1

192

5

Anesthesiology

1

1

192

Alfredo M. Rodriguez–Granillo

×

10

Publications

536

Citations

10

H-Index

YearCitations

Comparison of AngioJet Rheolytic Thrombectomy Before Direct Infarct Artery Stenting With Direct Stenting Alone in Patients With Acute Myocardial Infarction

Angela Migliorini, Amerigo Stabile, Alfredo E. Rodríguez,

Journal of the American College of Cardiology

2010

192

Oral Rapamycin After Coronary Bare-Metal Stent Implantation to Prevent Restenosis

Alfredo E. Rodríguez, Juan F. Granada, Máximo Rodriguez‐Alemparte,

Journal of the American College of Cardiology

2006

97

Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry

Alfredo E. Rodríguez, Andrew Maree, Juan Mieres,

European Heart Journal

2007

89

Revascularization strategies of coronary multiple vessel disease in the Drug Eluting Stent Era: one year follow-up results of the ERACI III Trial.

Alfredo E. Rodríguez, Liliana Grinfeld, Carlos Fernandez‐Pereira,

PubMed

2006

40

One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: Results from the DiabEtic Argentina Registry (DEAR)

Juan Mieres, Carlos Fernández‐Pereira, Gustavo Risau,

Cardiovascular revascularization medicine

2012

28

Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study

Andrew Maree, Sonia Tarragona, Carlos Fernández‐Pereira,

EuroIntervention

2009

25

Second vs. First generation drug eluting stents in multiple vessel disease and left main stenosis: Two‐year follow‐up of the observational, prospective, controlled, and multicenter ERACI IV registry

Carlos Haiek, Carlos Fernández‐Pereira, Omar Santaera,

Catheterization and Cardiovascular Interventions

2016

21

Randomized comparison of cost‐saving and effectiveness of oral rapamycin plus bare‐metal stents with drug‐eluting stents: Three‐year outcome from the randomized oral rapamycin in Argentina (ORAR) III trial

Alfredo E. Rodríguez, Alfredo M. Rodriguez–Granillo, David Antoniucci,

Catheterization and Cardiovascular Interventions

2011

18

Efficacy and safety of a double‐coated paclitaxel‐eluting coronary stent: The EUCATAX trial

Alfredo E. Rodríguez, Cesar F. Vigo, Alejandro Delacasa,

Catheterization and Cardiovascular Interventions

2010

14

Comparison of Cost-Effectiveness of Oral Rapamycin Plus Bare-Metal Stents Versus First Generation of Drug-Eluting Stents (from the Randomized Oral Rapamycin in Argentina [ORAR] 3 Trial)

Alfredo E. Rodríguez, Igor F. Palacios, Alfredo M. Rodriguez–Granillo,

The American Journal of Cardiology

2013

12

Page 1